The Stressed Importance of MS Center Care and Multidisciplinary Teams in Multiple Sclerosis: Marisa McGinley, DO
The staff neurologist at Cleveland Clinic’s Mellen Center for MS detailed some of the negative impacts issues with access to neurologists and MS care centers can have on patient diagnosis and longterm prognosis. [WATCH TIME: 4 minutes]
WATCH TIME: 4 minutes
"If they have bladder symptoms, spasticity problems, or gait issues, as a neurologist, we can start to address those things, but we often need a really good multidisciplinary team to care for these patients long term."
The care for patients with multiple sclerosis (MS) often incorporates several different specialists in addition to a traditional neurologist. These patients experience a range of difference symptoms, including fatigue, numbness and tingling, loss of balance, tremor, pain, bladder problems, bowel trouble, vision issues, and problems with memory and thinking. Comorbidities are also common throughout the disease course, from symptom onset through diagnosis to the end of life.
Earlier this year, a group of investigators published research on the geographic disparities in access to neurologists and MS care in the US with over 70,000 census tracts included. Led by
In an interview with NeurologyLive®, McGinley, a staff neurologist at Cleveland Clinic’s Mellen Center for MS, discussed some of the negative downstream effects limited access to neurologists and MS care centers has on patients with MS. She spoke specifically on the importance of timely diagnosis and early intervention, as well as the considerable need for multidisciplinary specialists that alleviate the workload of general neurologists.
REFERENCE
1. McGinley M, Harvey T, Lopez R, Ontaneda D, Buchalter RB. Geographic disparities in access to neurologists and multiple sclerosis care in the united states. Neurology. 2024;102(2). doi:10.1212/WNL.00000000000207916
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Related Articles
- Del-Zota Reverses Duchenne Disease Progression in 1-Year Trial Update
September 15th 2025
- 2025 Women in Neurology Conference: Educating, Mentoring, and Networking
September 15th 2025
- This Week on NeurologyLive® — September 15, 2025
September 15th 2025
- NeurologyLive® Brain Games: September 14, 2025
September 14th 2025